Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy

Rusan Catar(Humboldt-Universität zu Berlin), Janusz Witowski(Poznan University of Medical Sciences)
Frontiers in Immunology
February 4, 2022
Cited by 17


Related Papers